Your browser is no longer supported. Please, upgrade your browser.
DVAX Dynavax Technologies Corporation monthly Stock Chart
DVAX [NASD]
Dynavax Technologies Corporation
Index- P/E- EPS (ttm)-3.45 Insider Own0.36% Shs Outstand38.43M Perf Week-19.37%
Market Cap707.11M Forward P/E- EPS next Y-2.56 Insider Trans0.07% Shs Float38.29M Perf Month-26.49%
Income-102.20M PEG- EPS next Q-0.75 Inst Own87.00% Short Float13.77% Perf Quarter-29.01%
Sales5.60M P/S126.27 EPS this Y9.90% Inst Trans0.07% Short Ratio5.32 Perf Half Y-37.24%
Book/sh5.78 P/B3.18 EPS next Y22.20% ROA-68.30% Target Price47.00 Perf Year13.58%
Cash/sh5.74 P/C3.20 EPS next 5Y- ROE-88.60% 52W Range15.84 - 32.49 Perf YTD-23.84%
Dividend- P/FCF- EPS past 5Y14.50% ROI-82.90% 52W High-43.37% Beta2.36
Dividend %- Quick Ratio11.40 Sales past 5Y-22.90% Gross Margin- 52W Low16.16% ATR2.27
Employees197 Current Ratio11.40 Sales Q/Q-45.50% Oper. Margin- RSI (14)34.23 Volatility9.12% 10.32%
OptionableYes Debt/Eq0.00 EPS Q/Q27.40% Profit Margin- Rel Volume0.72 Prev Close18.21
ShortableYes LT Debt/Eq0.00 EarningsMar 03 BMO Payout- Avg Volume990.65K Price18.40
Recom1.80 SMA20-19.46% SMA50-25.60% SMA200-26.43% Volume717,716 Change1.04%
Nov-30-15Initiated RBC Capital Mkts Outperform $48
Nov-25-13Upgrade MLV & Co Hold → Buy $1.50 → $5
Feb-25-13Downgrade MLV & Co Buy → Hold
Nov-16-12Reiterated MLV & Co Buy $10 → $7.50
Jan-04-12Initiated MLV & Co Buy $8
Nov-09-10Reiterated Wedbush Outperform $6 → $8
Nov-08-10Initiated Jefferies Buy $4
May-13-10Upgrade Wedbush Neutral → Outperform $2.60 → $6
Mar-20-09Initiated Wedbush Morgan Buy $1.20
Oct-22-08Downgrade Oppenheimer Outperform → Perform
May-19-08Reiterated Susquehanna Financial Positive $7 → $5
May-19-08Downgrade Bear Stearns Outperform → Peer Perform
Mar-18-08Downgrade Merriman Curhan Ford Buy → Neutral
Feb-22-08Upgrade Oppenheimer Perform → Outperform $8.50
Oct-03-07Initiated Credit Suisse Outperform $8
Jun-06-07Initiated Susquehanna Financial Positive
Feb-26-07Downgrade JMP Securities Mkt Outperform → Mkt Perform
Feb-09-16 05:01PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers
Jan-25-16 08:05AM  Dynavax Technologies Corp. breached its 50 day moving average in a Bullish Manner : January 25, 2016
08:00AM  Strength Seen in Dynavax (DVAX): Stock Gains 11.1%
Jan-20-16 05:02PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex +9.30%
04:13PM  Dynavax, AstraZeneca Amend Deal for Asthma Candidate
Jan-19-16 04:00PM  Dynavax and AstraZeneca Amend Their Agreement for Asthma Drug Candidate Marketwired
Jan-14-16 09:30AM  The Zacks Analyst Blog Highlights: Baxalta, Juno, Horizon Pharma, AbbVie and Dynavax
Jan-13-16 04:14PM  Biotech Stock Roundup: Baxalta - Shire to Combine, JPM Healthcare Conference in Focus
Jan-12-16 08:06AM  Dynavax Technologies Corp. breached its 50 day moving average in a Bearish Manner : January 12, 2016 -5.51%
08:02AM  These Biotech Stocks Could Double in 2016 at Motley Fool
Jan-11-16 04:43PM  Dynavax to Present at J.P. Morgan 34th Annual Healthcare Conference Marketwired -6.57%
Jan-08-16 02:40PM  Dynavax's Heplisav-B Tops GlaxoSmithKline's Engerix-B -9.80%
08:15AM  Dynavax Technologies (DVAX) Catches Eye: Stock Up 40.2%
Jan-07-16 04:22PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits +40.23%
04:20PM  Why #JPM16 matters: Biotechs open news spigots ahead of big conference at bizjournals.com
03:40PM  Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial at Investor's Business Daily
02:51PM  Dynavax Hepatitis B Vaccine Beats Glaxo's In Trial at Investor's Business Daily
01:55PM  Dynavax Soars on Positive Late Stage Results
01:38PM  Why Are Investors Bullish On These Five Stocks On Thursday? at Insider Monkey
09:49AM  Dynavax Technologies Corporation's Stock Bolts Higher on Positive Clinical Update at Motley Fool
07:44AM  Dynavax's hep B vaccine meets goals in late-stage study
07:16AM  Dynavax's hep B vaccine meets main goals in late-stage study
07:00AM  Dynavax Reports Top Line Results of Phase 3 HEPLISAV-B(TM) Study Marketwired
Jan-06-16 05:04PM  Dynavax to Host Webcast Conference Call Tomorrow to Review HEPLISAV-B(TM) Phase 3 Clinical Data Marketwired -8.55%
Dec-29-15 08:12AM  Dynavax Technologies Corp. breached its 50 day moving average in a Bearish Manner : December 29, 2015
Dec-16-15 10:03AM  Dynavax Technologies Corp. Value Analysis (NASDAQ:DVAX) : December 16, 2015
Dec-15-15 01:00PM  Dynavax Technologies Corp. Earnings Analysis: Q3, 2015 By the Numbers +5.25%
09:03AM  Dynavax Technologies Corp. breached its 50 day moving average in a Bearish Manner : December 15, 2015
Dec-08-15 01:17PM  DYNAVAX TECHNOLOGIES CORP Financials
Dec-05-15 05:30PM  Dynavax Presents Clinical Data From Lead Cancer Immunotherapy Candidate, SD-101, at ASH Annual Meeting Marketwired
Dec-02-15 08:31AM  What Do Hedge Funds Think of Achillion Pharmaceuticals, Inc. (ACHN)? at Insider Monkey
Dec-01-15 11:14AM  Hedge Funds Are Buying Dynavax Technologies Corporation (DVAX) at Insider Monkey
Nov-30-15 04:00PM  Dynavax Announces Presentation of Clinical Data at ASH Annual Meeting Marketwired +6.33%
Nov-28-15 03:01PM  What Do Hedge Funds Think of Alamos Gold Inc (AGI)? at Insider Monkey
Nov-21-15 01:15PM  JPMorgan Likes These 5 Biotech Stocks at TheStreet
Nov-19-15 08:29AM  Dynavax Technologies Corp. breached its 50 day moving average in a Bullish Manner : November 19, 2015
Nov-12-15 04:06PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
Nov-05-15 04:43PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
07:29AM  Dynavax Technologies reports 3Q loss
07:00AM  Dynavax Reports Third Quarter 2015 Financial Results Marketwired
Nov-01-15 07:01AM  5 Top Stocks to Buy In November at Motley Fool
Oct-30-15 08:19AM  Why biotech could be on the verge of a rebound
Oct-14-15 09:47AM  Pullbacks Make Better Buys Of Amgen and Four Biotech Stocks at Forbes
Oct-12-15 02:50PM  Qiagen Poised on Molecular Diagnostics, International Business
Oct-08-15 04:15PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Dynavax Initiates Immuno-Oncology Clinical Trial Evaluating SD-101 in Combination With Merck's Anti-PD-1 Therapy, KEYTRUDA(R) (pembrolizumab) Marketwired
Sep-24-15 12:34PM  ETFs with exposure to Dynavax Technologies Corp. : September 24, 2015
10:30AM  Dynavax Technologies Corp. breached its 50 day moving average in a Bearish Manner : September 24, 2015
Sep-16-15 03:25PM  1 Smart Way to Play the Biotech Bounce at Motley Fool
Sep-15-15 05:02PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events
Sep-14-15 07:24AM  Dynavax Technologies (DVAX) Shares March Higher, Can It Continue?
Sep-09-15 03:38PM  6 stocks to watch at MarketWatch
Sep-03-15 09:00AM  Dynavax to Participate in Two Upcoming Investor Conferences Marketwired
Aug-09-15 08:13PM  10-Q for Dynavax Technologies Corp. at Company Spotlight
Aug-07-15 04:19PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:09PM  Dynavax Technologies reports 2Q loss
04:01PM  Dynavax Reports Second Quarter 2015 Financial Results Marketwired
Jul-28-15 08:00AM  Dynavax Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock Marketwired
Jul-22-15 04:08PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex +5.80%
08:15AM  Dynavax Prices Public Offering of Common Stock Marketwired
Jul-21-15 04:01PM  Dynavax Announces Proposed Public Offering of Common Stock Marketwired
Jul-09-15 04:22PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial +8.27%
02:01PM  Why Shares in Dynavax Technologies Corp Are Soaring 10% Higher Today at Motley Fool
01:40PM  Trending Now: Dynavax Technologiesn
09:00AM  Dynavax Announces Third Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) and Updates Financial Status Marketwired
Jul-07-15 09:46AM  Dynavax Technologies (DVAX) in Focus: Stock Up 8.2% - Tale of the Tape
06:00AM  4 Big-Volume Stocks to Trade for Breakouts at TheStreet
Jun-29-15 09:15AM  RA Capital Is Expecting A Breakthrough Cancer Drug From This Biotech at Insider Monkey
Jun-09-15 09:00AM  Dynavax to Present at the William Blair 35th Annual Growth Stock Health Care Conference Marketwired
Jun-02-15 10:30AM  Merck's Keytruda under Priority Review for Lung Cancer - Analyst Blog
Jun-01-15 12:01PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
May-28-15 04:54PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-09-15 08:09PM  10-Q for Dynavax Technologies Corp. at Company Spotlight
May-07-15 04:42PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:36PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
01:21PM  Dynavax Technologies reports 1Q loss
09:17AM  Dynavax Reports First Quarter 2015 Financial Results at noodls
09:00AM  Dynavax Reports First Quarter 2015 Financial Results Marketwired
May-06-15 08:08AM  Under $2 Stock Could Make Traders 200%-Plus Profits
Apr-17-15 12:13PM  The Shuman Law Firm Investigates Dynavax Technologies Corp. Business Wire
Mar-26-15 07:33PM  Lightning Round: This was a 'one and done' at CNBC -5.85%
07:13PM  Cramer Remix: I'm making a call on oil unrest at CNBC
Mar-25-15 06:04PM  Nasdaq stocks posting largest percentage increases AP -6.60%
Mar-23-15 12:13PM  ICYMI: Pharmaceutical Stocks Are Moving Big On Monday +10.79%
09:16AM  Stock Futures Aim Mildly Lower; Dollar Dips, Tenet Jumps On JV at Investor's Business Daily
Mar-19-15 10:46AM  Dynavax to Present at the Cowen and Company 35th Annual Health Care Conference at noodls
10:46AM  Dynavax to Present at the 2015 RBC Capital Markets' Global Healthcare Conference at noodls
10:46AM  Dynavax Reports Fourth Quarter and Year End 2014 Financial Results at noodls
10:46AM  Dynavax Announces Second Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) at noodls
Mar-16-15 07:27AM  Dynavax Technologies (DVAX) Shares March Higher, Can It Continue? - Tale of the Tape
Mar-07-15 07:08PM  10-K for Dynavax Technologies Corp. at Company Spotlight
Mar-05-15 05:19PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
05:11PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-K, Annual Report
06:48AM  Dynavax Technologies reports 4Q loss
06:00AM  Dynavax Reports Fourth Quarter and Year End 2014 Financial Results Marketwired
Mar-02-15 06:00AM  Dynavax Announces Second Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) Marketwired +6.87%
Feb-27-15 04:59PM  Dynavax to Present at the Cowen and Company 35th Annual Health Care Conference Marketwired
Feb-19-15 04:15PM  Dynavax to Present at the 2015 RBC Capital Markets' Global Healthcare Conference Marketwired
Feb-11-15 04:39PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh EDGAR Online
Feb-06-15 09:00AM  Dynavax Announces Laura Brege Has Joined Board of Directors and Denise Gilbert Will Retire Marketwired
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States. It development programs focus on the areas of vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. The company's product pipeline includes HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; SD-101, a CpG TLR9 agonist for the treatment of cancer immunotherapy that is in Phase I/II clinical trials; AZD1419, a drug candidate for the treatment of asthma, which has completed Phase I trial; DV1179, a TLR7/9 inhibitor that is in Phase I clinical trial for autoimmune or inflammatory conditions; and DV230-Nanoparticle, a second generation adjuvant that is in preclinical studies. It has a research collaboration and license agreement with AstraZeneca AB for the discovery and development of TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease; and strategic alliance with GlaxoSmithKline to discover, develop, and commercialize TLR inhibitors. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Janssen RobertVice PresidentOct 08Buy23.341002,334100Oct 09 04:08 PM
Plotkin Stanley ADirectorAug 26Option Exercise11.501,00011,5001,000Aug 26 04:49 PM